Howland Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $791K | Sell |
1,776
-199
| -10% | -$88.6K | 0.03% | 168 |
|
|
2025
Q1 | $958K | Buy |
1,975
+250
| +14% | +$121K | 0.04% | 151 |
|
|
2024
Q4 | $695K | Buy |
1,725
+39
| +2% | +$15.7K | 0.03% | 177 |
|
|
2024
Q3 | $784K | Buy |
1,686
+197
| +13% | +$91.6K | 0.03% | 168 |
|
|
2024
Q2 | $698K | Buy |
1,489
+653
| +78% | +$306K | 0.03% | 167 |
|
|
2024
Q1 | $349K | Sell |
836
-137
| -14% | -$57.3K | 0.02% | 216 |
|
|
2023
Q4 | $396K | Sell |
973
-48
| -5% | -$19.5K | 0.02% | 203 |
|
|
2023
Q3 | $355K | Sell |
1,021
-125
| -11% | -$43.5K | 0.02% | 202 |
|
|
2023
Q2 | $403K | Hold |
1,146
| – | – | 0.02% | 202 |
|
|
2023
Q1 | $361K | Buy |
+1,146
| New | +$361K | 0.02% | 206 |
|